Emerging Diseases

PVL linked with heightened S. aureus disease severity in children


Children with staphylococcal scarlet fever caused by Panton-Valentine leukocidin–positive Staphylococcus aureus strains had more exacerbated skin manifestations and greater systemic inflammatory responses compared with children who had strains that were negative for the cytotoxin.

“Clinical improvement after incision and drainage was achieved for most children with staphylococcal scarlet fever caused by Panton-Valentine leukocidin (PVL)–positive methicillin-resistant S. aureus strains, despite treatment with an ineffective antibiotic,” wrote the researchers from the Tri-Service General Hospital at the National Defense Medical Center in Taipei, Taiwan.

This is the first study conducted to prospectively compare children with staphylococcal scarlet fever with and without the presence of PVL, according to the researchers.

The researchers compared clinical characteristics and lab findings among 49 children who were treated for staphylococcal scarlet fever caused by community-associated S. aureus isolates during an 11-year study period and used multivariate analysis to determine the following:

  • 26 children had a methicillin-susceptible S. aureus isolate; 23 had a methicillin-resistant isolate.
  • 24 isolates, including five MSSA and 19 MRSA, were positive for PVL; 25 isolates (21 MSSA, 4 MRSA) were negative for PVL.
  • Children with PVL–positive isolates had significantly larger abscess sizes; higher white blood cell counts; higher C-reactive protein levels; and longer durations of fever, generalized scarlatiniform rashes and hospital stays.
  • Among the 19 PVL–positive MRSA isolates, 17 carried the staphylococcal cassette chromosome mec VT and all were multilocus sequence type 59.
  • Staphylococcus enterotoxin B was most common, with 92% of all isolates (23 MSSA, 22 MRSA) containing only that toxin.

Despite initiating antibiotic therapy within 24 hours of hospital admission for all patients, initial antibiotics were effective in only 53% of the patients; however, the researchers noted no significant association between ineffective antimicrobial therapy and clinical outcome.

Lo W-T. Clin Infect Dis. 2009;49:e69-e75.

The Pediatric SuperSite is intended for physician use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will the Pediatric SuperSite be used for medical advice to patients.

There are no comments for this article. Be the first to comment.

Infectious Diseases in Children Symposium

Headaches in Children and Adolescents Pediatric Annals, July 2010Enhancing Your Pediatric Practice Pediatric Annals, June 2010Sports Medicine in the Pediatric Office Pediatric Annals, May 2010
View more CME


WHO to consider 2020 global measles eradication goal

During the next year, WHO officials may take a major step toward worldwide measles eradication. With five of the six WHO regions having already declared eradication goals, the organization is considering the feasibility of a worldwide eradication goal by 2020.


Full Story
Google Analytics Alternative